Últimos Artículos de Diabetes, Obesity and Metabolism
- Correction to “Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study”
- A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
- Tirzepatide in the NHS: The known unknowns of treating obesity at a national scale
- Prevalence of overweight and obesity in adults from the Middle East: A large‐scale population‐based study
- Meta‐analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders‐European Chapter (IFSO‐EC) guidelines on multimodal strategies for the surgical treatment of obesity
- Comparative efficacy of different functional hydrogel dressings in healing diabetic foot ulcer: A systematic review and network meta‐analysis
- Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP‐1RA‐based weight‐loss therapies
- Population‐level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial
- Single‐cell transcriptional profiling reveals cellular senescence and inflammatory persistence as key features of type 1 diabetes partial remission
- Heterogeneous effects of obesity on all‐cause mortality: A causal forest analysis of hospitalized patients in China
- Frequency and sequence of proteinuria positivity and clinical outcomes in patients with diabetes: A nationwide cohort study
- Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico
- Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies
- Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States
- Oppositely biased glucagon‐like peptide‐1 receptor agonism does not differentially affect lipid metabolism in APOE*3‐Leiden CETP mice
- Adverse drug reaction patterns of GLP‐1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database
- Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta‐analysis of non‐Asian studies
- Estimating healthcare resource utilisation and cardiovascular events in people with high body mass index and established cardiovascular disease
- Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
- Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018